A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.
about
Update in lung cancer 2007Chemotherapy and surgery versus surgery alone in non-small cell lung cancerIncreased expression of integrin-linked kinase is associated with shorter survival in non-small cell lung cancerOptimising surgical management of elderly cancer patients.Surgery in 2013 and beyondNeoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancerSystemic and targeted therapies for early-stage lung cancer2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancerPreoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant dataEvaluation of nephroprotective and immunomodulatory activities of antioxidants in combination with cisplatin against murine visceral leishmaniasisPostinduction positron emission tomography assessment of N2 nodes is not associated with ypN2 disease or overall survival in stage IIIA non-small cell lung cancerUFT plus oral leucovorin calcium (Orzel) and radiation in combined modality therapy: a comprehensive review.Ifosfamide, cisplatin and etoposide combination in locally advanced inoperable non-small-cell lung cancer: a phase II study.Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB nonsmall cell lung carcinoma: an Italian Lung Cancer Project Observational Study.Prognostic factors and long term results of neo adjuvant therapy followed by surgery in stage IIIA N2 non-small cell lung cancer patients.Management of lung cancerThe long-term prognosis of induction chemotherapy followed by surgery for N2 non-small cell lung cancer: A retrospective case series study.Is there a role for adjuvant therapy for resected non-small cell lung cancer?Combined modality therapy in Stage IIIA non-small cell lung cancer: clarity or confusion despite the highest level of evidence?Efficacy of postoperative radiotherapy in patients with pathological stage N2 epidermal growth factor receptor wild type adenocarcinoma and squamous cell carcinoma lung cancerSurgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trialNeoadjuvant chemotherapy in stage IIIa non-small cell lung cancer.Role of multimodality treatment for lung cancer.The role of induction therapy in the management of resectable non-small cell lung cancer.The Role of Neoadjuvant Trials in Drug Development for Solid Tumors.Mediastinal staging of non-small-cell lung cancer.Preoperative bevacizumab in combination with paclitaxel and carboplatin in surgically resectable non-small cell lung cancerPlatinum drugs in the treatment of non-small-cell lung cancerLung cancer--where are we today? Current advances in staging and nonsurgical treatment.Lung cancer. 4: chemotherapy for non-small cell lung cancer: the end of the beginning.Neoadjuvant chemotherapy and chemoradiotherapy for non-small cell lung cancer: current status and future prospects.Neoadjuvant EGFR TKIs: toward personalized management in non-small-cell lung cancer.Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.BTS guidelines: guidelines on the selection of patients with lung cancer for surgery.Clinical significance in the number of involved lymph nodes in patients that underwent surgery for pathological stage III-N2 non-small cell lung cancerA systematic overview of radiation therapy effects in non-small cell lung cancer.Bone marrow micrometastasis is associated with both disease recurrence and poor survival in surgical patients with node-negative non-small-cell lung cancer: a meta-analysis.Combined modality treatment of non-small-cell lung cancer.Prognostic factors of resected node-positive lung cancer: location, extent of nodal metastases, and multimodal treatment.Phase II study of biomarker-guided neoadjuvant treatment strategy for IIIA-N2 non-small cell lung cancer based on epidermal growth factor receptor mutation status.
P2860
Q22241904-0F2A31FD-0DB3-426A-A4C5-E6A656A96034Q24244191-FA4CA1FC-FD79-43CD-ACFD-F3148C140F50Q24795806-A55A20D9-ED7D-4194-9E86-78CB5E0BFBDAQ24796933-9A02DCBC-4F5F-4606-B806-5106E327EE31Q26863046-8909848D-3359-44AC-9C60-5AC184264D14Q26863742-DEB47A54-23FB-4D35-81BC-4A76F43ED0E9Q26865490-9C39C753-3BB8-451E-BFEC-1A160A1C6D8DQ27002509-C34DEA35-9E96-41FF-A01F-7EB8F02EC16DQ27010262-E3167BA3-E403-4CFF-80F6-121C1D3D963EQ28483086-D8084DAA-E989-41A9-B9F5-A0039C3DBA04Q30730531-C7F6522E-6B02-4DB3-BAFB-6CD53799C573Q32160328-7C05CB98-304A-46C8-BAF1-47E88C44FBFAQ33330751-F96FA8AD-62E5-43DA-8610-AECEBD42A6FFQ33348744-F0C445D3-899F-46DC-AEA6-FBF7CBACA868Q33568631-A3F2EA98-11A1-4542-A2EC-0365A43EB5B9Q33583714-7AA01A1C-E7C0-46D9-838D-869A8BB465F2Q33613087-8A7500E1-73B9-4352-A3D2-957DDA7FAF39Q33714028-7073F907-7CD8-469C-B597-8C326FD03C6CQ33716531-B7EA8745-56BA-4AEE-8797-7EF89C0DF05AQ33798819-1739DE73-2F95-4561-BBED-DCE1A0F1D42EQ33813436-BA64F746-23BA-4D97-BCB5-818CC86C76ADQ33821310-41218027-3E5B-4D82-8136-36A52ABB4CC4Q33829263-B0011193-D634-480A-AD67-DCE44FD5D530Q33877447-C44E2327-6FB7-4D32-AF10-3A60E1204CD3Q33886353-24021537-2AC6-4B41-B95A-972162F6A494Q34325208-5C72FBCB-1750-4610-8F32-FB998097A610Q34743088-45CFA4B9-08E9-4DA7-8C5E-B476DF57C99FQ34954760-06E0D6DC-710F-430F-A5F7-4C2929532653Q34982142-04905B7B-C184-437A-81C8-75946A9901A0Q35096015-B0C09B1F-CF63-4CF1-9E82-5088F533347EQ35143926-F96066A9-A2F8-49D5-BC34-CF40B9E8BB34Q35200329-431B54FE-0D60-4065-9365-053B67017F93Q35532111-42C9BC36-0590-419C-B4AE-FD48C45CCB4DQ35534347-AFCCA01A-AB93-494D-B0BC-B0F85A80C51FQ35540726-FA50847A-6162-4E22-AECB-B43A1EE1C7E7Q35574863-FF4DB5AD-25EF-492A-9940-EEF7B6CA0927Q35604934-11538853-3F4D-4F9C-B517-595F7A278457Q35627621-2D482C3C-460B-496C-8D86-7100EF000439Q35634785-E06193F1-8784-4422-B968-E25E6E1A2820Q35681695-08D0C8CC-8C45-4797-B181-B6F689A24378
P2860
A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
A randomized trial comparing p ...... IA non-small-cell lung cancer.
@en
A randomized trial comparing p ...... IA non-small-cell lung cancer.
@nl
type
label
A randomized trial comparing p ...... IA non-small-cell lung cancer.
@en
A randomized trial comparing p ...... IA non-small-cell lung cancer.
@nl
prefLabel
A randomized trial comparing p ...... IA non-small-cell lung cancer.
@en
A randomized trial comparing p ...... IA non-small-cell lung cancer.
@nl
P2093
P356
P1476
A randomized trial comparing p ...... IA non-small-cell lung cancer.
@en
P2093
Fossella F
McGavran M
Putnam JB Jr
P304
P356
10.1093/JNCI/86.9.673
P407
P577
1994-05-01T00:00:00Z